StockSelector.com
  Research, Select, & Monitor Saturday, April 20, 2019 8:13:21 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Concert Pharmaceuticals Inc.$9.44($.40)(4.07%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Concert Pharmaceuticals Inc. has an overall rank of 6054 out of 6824 stocks based on 7 positive rankings and 8 negative rankings.

Positive Rankings
Oversold RSI
The 14 Day Relative-Strength Index for Concert Pharmaceuticals Inc. is 24.6. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Concert Pharmaceuticals Inc. is ranked 54.
Oversold Stochastics
Concert Pharmaceuticals Inc. rank is 156
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Concert Pharmaceuticals Inc. is ranked 190.
Debt-to-Equity
Concert Pharmaceuticals Inc. rank is 298
Low vPut/Call
Concert Pharmaceuticals Inc. has a low Put/Call ratio of 0.21 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 427.
Low Put/Call
Concert Pharmaceuticals Inc. has a low Put/Call ratio of 0.31 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 793.
Price-to-Book
Concert Pharmaceuticals Inc. rank is 1451
Negative Rankings
10 Day Loss
Concert Pharmaceuticals Inc. rank is 73
Negative Revenue Growth
Concert Pharmaceuticals Inc. rank is 176
Negative Net Margin
Concert Pharmaceuticals Inc. rank is 236
Price-to-Sales
Concert Pharmaceuticals Inc. rank is 270
90 Day Loss
Concert Pharmaceuticals Inc. rank is 469
Negative ROA
Concert Pharmaceuticals Inc. rank is 689
Down EPS Surprise
Concert Pharmaceuticals Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROE
Concert Pharmaceuticals Inc. rank is 745







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.